Moderna is unlikely to match the valuations of large pharmaceutical giants

[ad_1]

Driven by the COVID vaccine, Moderna’s valuation has now surpassed that of well-known large pharmaceutical giants such as Bristol-Myers Squibb and Sanofi. Can it last? read more

[ad_2]

Source link